Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

"Abbott Laboratories began its 125th year with approximately ... "For our shareholders, we are developing the kind of essential, life-enhancing products that will ensure the enduring growth ...

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

We recently published a list of the 8 Most Profitable Dividend Stocks to Buy Now. In this article, we are going to take a ...

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in ...

Abbott Laboratories ABT has witnessed strong momentum ... manufactures and sells a diversified line of healthcare products. The company has four reportable segments, namely, Established ...

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.

Valued at a market cap of $228.3 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells healthcare products. The company operates in ...

Abbott Laboratories (NYSE ... Abbott announced that it earned a CE mark in Europe for its Volt PFA System, a product used to treat people with atrial fibrillation (a common heart disorder).

A St. Louis judge has granted a new trial in a case Abbott Laboratories won in the fall, in which a mother alleged that the company’s cow’s milk-based products for premature infants ...